home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Revolution Medicines Announces Proposed Public Offering of Common Stock
Revolution Medicines Announces Proposed Public Offering of Common Stock
Post navigation
Previous Post
Previous
Turning Point Therapeutics Reports Updated Interim Data From Registrational Phase 2 Trident-1 Study of Repotrectinib in Patients With ROS1-Positive TKI-Naïve Non-Small Cell Lung Cancer
Next Post
Next
MOMA Therapeutics Appoints Asit Parikh, M.D., Ph.D. as President and Chief Executive Officer